Crypto Blockchain Industries S.A. buy Traumtanz
Start price
18.02.23
/
50%
€0.73
Target price
18.02.24
€1.00
Performance (%)
-7.37%
End price
23.02.23
€0.68
Summary
This prediction ended on 23.02.23 with a price of €0.68. With a performance of -7.37%, the BUY prediction for Crypto Blockchain Industries S.A. by Traumtanz closed slightly in the red. Traumtanz has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Crypto Blockchain Industries S.A. | -13.600% | -13.600% | -50.909% |
iShares Core DAX® | -1.180% | 0.780% | 12.701% |
iShares Nasdaq 100 | -2.823% | -2.419% | 28.746% |
iShares Nikkei 225® | -3.908% | 1.574% | 11.146% |
iShares S&P 500 | -1.012% | -0.335% | 27.036% |
According to Traumtanz what are the pros and cons of Crypto Blockchain Industries S.A. for the foreseeable future?
Pros
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
High dividend yield expected
Standard Investments for future growth
Valuable balance sheet
Normal challenges to pay loans and raise capital
Capable Management
Good culture
Innovative
Some uniques
Differentiated customer and product portfolio
Growths faster than the competition
Sustainability is important
Stable Large shareholder and/or long term investor
Medium risks for its business
Top 10 in its market
Small cyclical dependencies
Known brand
Future proof or reliable business model
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Good rating
ROE higher than 10% per year
Cons
Comments by Traumtanz for this prediction
In the thread Crypto Blockchain Industries S.A. diskutieren
Buy mit Kursziel 1,0
In the thread Trading Crypto Blockchain Industries S.A.
Buy beendet
Stopped prediction by Traumtanz for Crypto Blockchain Industries S.A.
Crypto Blockchain Industries S.A.
Start price
Target price
Perf. (%)
€1.38
04.02.23
04.02.23
-
02.05.24
02.05.24
-31.26%
09.02.23
09.02.23
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation